Seeds as a production system for molecular pharming applications: Status and prospects

Current Pharmaceutical Design

Volumn 19, Issue 31, 2013, Pages 5543-5552

  Sabalza, Maite ^a   Vamvaka, Evagelia ^a   Christou, Paul ^a,b   Capell, Teresa ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Infectious diseases; Plant made pharmaceuticals; Recombinant antibodies; Recombinant proteins

Indexed keywords

ANTIGEN; ENZYME INHIBITOR; GLYCOPROTEIN; GROWTH FACTOR; HORMONE; INDUSTRIAL ENZYME; PEPTIDE; RECOMBINANT PROTEIN; SEED STORAGE PROTEIN; VACCINE;

ARABIDOPSIS THALIANA; BARLEY; CELL VACUOLE; CEREAL; DEVELOPING COUNTRY; ENCAPSULATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LEGUME; MAIZE; MOLECULAR FARMING; NONHUMAN; PEA; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN TARGETING; QUALITY CONTROL; QUANTITATIVE ASSAY; RAPESEED; REVIEW; RICE; SAFFLOWER; TOBACCO; WHEAT;

ANIMALS; ANTIGENS; DEVELOPING COUNTRIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MOLECULAR FARMING; PLANT PROTEINS; RECOMBINANT PROTEINS; SEEDS; TRANSGENES; VACCINES;

EID: 84881349732     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319310009     Document Type: Review

References (148)

1. Ma JK, Drake PM, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 2003; 4: 794-805.
2. Twyman RM, Stöger E, Schillberg S, Christou P, Fischer R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol 2003; 21: 570-578.
3. Fischer R, Stöger E, Schillberg S, Christou P, Twyman RM. Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 2004; 7: 152-158.
4. Stöger E, Ma JK, Fischer R, Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 2005; 16: 167-173.
5. Stöger E, Vaquero C, Torres E, et al. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 2000; 42: 583-590.
6. Moloney M, Boothe J, van Rooijen G. Oil bodies and associated proteins as affinity matrices Canada: SemBioSys Genetics Inc, Calgary 1999: Patent: 5856452: 1-17.
7. Schillberg S, Emans N, Fischer R. Antibody molecular farming in plants and plant cells. Phytochem Rev 2002; 1: 45-54.
8. Peters J, Stöger E. Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum Vaccines 2011; 7: 367-374.
9. Potenza C, Aleman L, Sengupta-Gopalan C. Targeting transgene expression in research, agricultural, and environmental applications: Promoters used in plant transformation. In vitro Cell Dev-Pl 2004; 40: 1-22.
10. Petruccelli S, Otegui MS, Lareu F, et al. A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol J 2006; 4: 511-527.
11. Menkhaus TJ, Bai Y, Zhang C, Nikolov ZL, Glatz CE. Considerations for the recovery of recombinant proteins from plants. Biotechnol Progr 2004; 20: 1001-1014.
12. Baez J, Russell D, Craig J, Cass PL. Corn seed production of therapeutic proteins moves forward. Biopharm Int 2000; 13: 50-54.
13. Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 2001; 6: 219-226.
14. Nandi S, Suzuki YA, Huang J, et al. Expression of human lactoferrin in transgenic rice grains for the application in infant formula. Plant Sci 2002; 163: 713-722.
15. Zhu Z, Hughes KW, Huang L, Sun B, Liu C, Li Y. Expression of human-interferon cDNA in transgenic rice plants. Plant Cell Tiss Org 1994; 36: 197-204.
16. Huang N, Yang D. Production of human growth factors in monocot seeds. USA, 2004: Patent: 20040078851.
17. Dieryck W, Pagnier J, Poyart C, et al. Human haemoglobin from transgenic tobacco. Nature 1997; 386: 29-30.
18. Ye X, Al-Babili S, Kloti A, et al. Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 2000; 287: 303-305.
19. Nochi T, Takagi H, Yuki Y, et al. Rice-based mucosal vaccine as a global strategy for cold-chain and needle-free vaccination. Proc Natl Acad Sci USA 2007; 104: 10986-10991.
20. Streatfield SJ, Howard JA. Plant-based vaccines. Int J Parasitol 2003; 33: 479-493.
21. Wu J, Yu L, Li L, Hu J, Zhou J, Zhou X. Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 2007; 5: 570-578.
22. Eskelin K, Ritala A, Suntio T, et al. Production of a recombinant full-length collagen type I-1 and of a 45-kDa collagen type I-1 fragment in barley seeds. Plant Biotechnol J 2009; 7: 657-672.
23. Hood EE, Love R, Lane J, et al. Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed. Plant Biotechnol J 2007; 5: 709-719.
24. Schünmann PHD, Coia G, Waterhouse PM. Biopharming the SimpliRED™ HIV diagnostic reagent in barley, potato and tobacco. Mol Breeding 2002; 9: 113-121.
25. Hood EE, Woodard SL, Horn ME. Monoclonal antibody manufacturing in transgenic plantsmyths and realities. Curr Opin Biotechnol 2002; 13: 630-635.
26. Perrin Y, Vaquero C, Gerrard I, et al. Transgenic pea seeds as bioreactors for the production of a single-chain Fv fragment (scFV) antibody used in cancer diagnosis and therapy. Mol Breeding 2000; 6: 345-352.
27. Zeitlin L, Olmsted SS, Moench TR, et al. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 1998; 16: 1361-1364.
28. Tackaberry ES, Dudani AK, Prior F, et al. Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 1999; 17: 3020-3029.
29. Scheller J, Leps M, Conrad U. Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides. Plant Biotechnol J 2006; 4: 243-249.
30. Nykiforuk CL, Boothe JG, Murray EW, et al. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 2006; 4: 77-85.
31. Szarka S, van Rooijen G, Moloney M. Methods for the production of multimeric immunoglobulins, and related compositions. SemBioSys Genetics Inc 2006: Patent: 7098383.
32. Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 2004; 22: 4385-4389.
33. Monsanto Protein Technology and NeoRx Corporation. [Accessed online 27 August 2012]; Available at: http: //www.mpt.monsanto.com/andhttp://www.neorx.com/.
34. Samyn-Petit B, Gruber V, Flahaut C, et al. N-glycosylation poten-tial of maize: The human lactoferrin used as a model. Glycoconjugate J 2001; 18: 519-527.
35. Gomez N, Wigdorovitz A, Castanon S, et al. Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch Virol 2000; 145: 1725-1732.
36. Petolino JF, Young S, Hopkins N, et al. Expression of murine adenosine deaminase (ADA) in transgenic maize. Transgenic Res 2000; 9: 1-9.
37. Zhong G-Y, Peterson D, Delaney DE, Bailey M, Witcher DR, James C Register III, et al. Commercial production of aprotinin in transgenic maize seeds. Mol Breeding 1999; 5: 345-356.
38. Gruber V, Berna PP, Arnaud T, et al. Large-scale production of a therapeutic protein in transgenic tobacco plants: effect of subcellular targeting on quality of a recombinant dog gastric lipase. Mol Breeding 2001; 7: 329-340.
39. Hood EE, Witcher DR, Maddock S, et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breeding 1997; 3 (4): 291-306.
40. Woodard SL, Mayor JM, Bailey MR, et al. Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Bioc 2003; 38: 123-130.
41. Streatfield SJ, Jilka JM, Hood EE, et al. Plant-based vaccines: unique advantages. Vaccine 2001; 19: 2742-2748.
42. Lamphear BJ, Barker DK, Brooks CA, et al. Expression of the sweet protein brazzein in maize for production of a new commercial sweetener. Plant Biotechnol J 2005; 3: 103-114.
43. Rademacher T, Sack M, Arcalis E, et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 2008; 6: 189-201.
44. Ramessar K, Rademacher T, Sack M, et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 2008; 105: 3727-3732.
45. Hayden CA, Streatfield SJ, Lamphear BJ, et al. Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen. Vaccine 2012; 30: 2937-2942.
46. Srivastava HS, Asthana JS, Jain A. Induction of Nitrate Reductase and Peroxidase Activity in the Seedlings of Normal and High Lysine Maize. Physiol Plantarum 1979; 47: 119-123.
47. Zhong Q, Gu Z, Glatz CE. Extraction of Recombinant Dog Gastric Lipase from Transgenic Corn Seed. J Agr Food Chem 2006; 54: 8086-8092.
48. EPlcyte [Accessed online 27 August 2012]; Available at: http://www.epicyte.com.
49. Kusnadi AR, Evangelista RL, Hood EE, Howard JA, Nikolov ZL. Processing of transgenic corn seed and its effect on the recovery of recombinant beta-glucuronidase. Biotechnol Bioeng 1998; 60: 44-52.
50. Guerrero-Andrade O, Loza-Rubio E, Olivera-Flores T, Fehérvári-Bone T, Gómez-Lim MA. Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res 2006; 15: 455-463.
51. Ludwig DL, Witte L, Hicklin DJ, et al. Conservation of receptor antagonist antitumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed. Hum Antibodies 2004; 13: 81-90.
52. Drakakaki G, Marcel S, Glahn RP, et al. Endosperm-specific coexpression of recombinant soybean ferritin and Aspergillus phytase in maize results in significant increases in the levels of bioavailable iron. Plant Mol Biol 2005; 59: 869-880.
53. Chen R, Xue G, Chen P, et al. Transgenic maize plants expressing a fungal phytase gene. Transgenic Res 2008; 17: 633-643.
54. Stöger E, Sack M, Perrin Y, et al. Practical considerations for pharmaceutical antibody production in different crop systems. Mol Breeding 2002; 9: 149-158.
55. Xie T, Qiu Q, Zhang W, et al. A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery. Peptides 2008; 29: 1862-1870.
56. Rachmawati D, Mori T, Hosaka T, Takaiwa F, Inoue E, Anzai H. Production and characterization of recombinant human lactoferrin in transgenic Javanica rice. Breeding Sci 2005; 55: 213-222.
57. Huang N. High-level protein expression system uses self-pollinating crops as hosts. Bioprocess Int 2004; 2: 54-59.
58. Yang D, Guo F, Liu B, Huang N, Watkins S. Expression and localization of human lysozyme in the endosperm of transgenic rice. Planta 2003; 216: 597-603.
59. Oszvald M, Kang TJ, Tomoskozi S, et al. Expression of a synthetic neutralizing epitope of porcine epidemic diarrhea virus fused with synthetic B subunit of Escherichia coli heat labile enterotoxin in rice endosperm. Mol Biotechnol 2007; 35: 215-223.
60. Takaiwa F, Takagi H, Hirose S, Wakasa Y. Endosperm tissue is good production platform for artificial recombinant proteins in transgenic rice. Plant Biotechnol J 2007; 5: 84-92.
61. Alli Z, Sardana RK, Pierre B, et al. Pharming vaccines for hepatitis and cytomegalovirus: Towards the development of multivalent and subunit vaccines for oral delivery of antigens. Phytochemistry Rev 2002; 1: 55-66.
62. Wakasa Y, Zhao H, Hirose S, et al. Antihypertensive activity of transgenic rice seed containing an 18-repeat novokinin peptide localized in the nucleolus of endosperm cells. Plant Biotechnol J 2011; 9: 729-735.
63. Qian-feng L, Qiao-quan L, Da-jiang Z, et al. Expression of Recombinant Phytase in Transgenic Rice. Chinese J Rice Sci 2006; 20: 243-247.
64. Capell T, Claparols I, Del Duca S, et al. Producing transglutaminases by molecular farming in plants: Minireview article. Amino Acids 2004; 26: 419-423.
65. Zhang D, Nandi S, Bryan P, et al. Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.). Protein Expres Purif 2010; 74: 69-79.
66. Sardana R, Dudani AK, Tackaberry E, et al. Biologically active human GM-CSF produced in the seeds of transgenic rice plants. Transgenic Res 2007; 16: 713-721.
67. Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, et al. A recombinant multimeric immunoglobulin expressed in rice shows assembly dependent subcellular localization in endosperm cells. Plant Biotechnol J 2005; 3: 115-127.
68. Qiao-quan L, Qian-feng L, Li J, et al. Transgenic expression of the recombinant phytase in rice (Oryza sativa). IRRN 2007; 32: 44.
69. Takaiwa F, Hirose S, Takagi H, Yang L, Wakasa Y. Deposition of a recombinant peptide in ER-derived protein bodies by retention with cysteine-rich prolamins in transgenic rice seed. Planta 2009; 229: 1147-1158.
70. Suzuki K, Kaminuma O, Yang L, et al. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without by stander suppression. Plant Biotechnol J 2011; 9: 982-990.
71. Shigemitsu T, Ozaki S, Saito Y, et al. Production of human growth hormone in transgenic rice seeds: cointroduction of RNA interference cassette for suppressing the gene expression of endogenous storage proteins. Plant Cell Rep 2012; 31: 539-549.
72. Wright KE, Prior F, Sardana R, et al. Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco. Transgenic Res 2001; 10: 177-181.
73. Leite A, Kemper EL, da Silva MJ, et al. Expression of correctly processed human growth hormone in seeds of transgenic tobacco plants. Mol Breeding 2000; 6: 47-53.
74. Altenbach SB, Pearson KW, Meeker G, Staraci LC, Sun SM. Enhancement of the methionine content of seed proteins by the expression of a chimeric gene encoding a methionine-rich protein in transgenic plants. Plant Mol Biol 1989; 13: 513-522.
75. Petruccelli S, Otegui MS, Lareu F, et al. A KDEL tagged mono-clonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol J 2006; 4: 511-527.
76. Sardana R, Ganz PR, Dudani A,Tackaberry ES, Cheng X, Altosaar I. Synthesis of Recombinant Human Cytokine GM-CSF in the Seeds of Transgenic Tobacco Plants. In: Recombinant Proteins from Plants: Production and Isolation of Clinically Useful Compounds 1997; 77-87.
77. Fiedler U, Conrad U. High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology (NY) 1995; 13: 1090-1093.
78. Floss DM, Conrad U. Expression of Complete Antibodies in Transgenic Plants. In: Antibody Engineering 2010; 489-502.
79. Lombardi R, Donini M, Villani ME, et al. Production of different glycosylation variants of the tumourtargeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Transgenic Res 2012: 1-17.
80. Yasawardene SG, Lomonossoff GP, Ramasamy R. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus. Indian J Med Res 2003; 118: 115-124.
81. Carrillo C, Wigdorovitz A, Oliveros JC, et al. Protective Immune Response to Foot and Mouth Disease Virus with VP1 Expressed in Transgenic Plants. J Virol 1998; 72: 1688-1690.
82. Canizares MC, Lomonossoff GP, Nicholson L. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert Rev Vaccines 2005; 4: 687-697.
83. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 2007; 25: 1647-1657.
84. Cunha N, Murad A, Cipriano T, et al. Expression of functional recombinant human growth hormone in transgenic soybean seeds. Transgenic Res 2011; 20: 811-826.
85. Vimolmangkang S, Gasic K, Soria-Guerra R, Rosales-Mendoza S, Moreno-Fierros L, Korban SS. Expression of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus in soybean seed yields an immunogenic antigenic protein. Planta 2012; 235: 513-522.
86. Yamada Y, Nishizawa K, Yokoo M, et al. Anti-hypertensive activity of genetically modified soybean seeds accumulating novokinin. Peptides 2008; 29: 331-337.
87. Vandekerckhove J, van Damme J, van Lijsebettens M, et al. En-kephalins Prouduced in Transgenic Plants Using Modified 2S Seed Storage Proteins. Nat Biotechnol 1989; 7: 929-932.
88. Lau OS, Ng DW, Chan WW, Chang SP, Sun SS. Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J 2010; 8: 994-1004.
89. Loos A, van Droogenbroeck B, Hillmer S, et al. Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 2011; 9: 179-192.
90. Markley N, Nykiforuk C, Boothe J, Moloney M. Producing Proteins Using Transgenic Oilbody-Oleosin Technology. BioPharm Int 2006; 19: 34.
91. van Droogenbroeck B, Cao J, Stadlmann J, et al. Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc Natl Acad Sci 2007; 104: 1430-1435.
92. Wang B, Ma M, Wu T. Aptamers improve the expression of a human granulocyte macrophage colony stimulating factor in transgenic Arabidopsis thaliana seeds. J Plant Biol 2007; 50: 29-37.
93. Sullivan S, Ralet MC, Berger A, et al. CESA5 is required for the synthesis of cellulose with a role in structuring the adherent mucilage of Arabidopsis seeds. Plant Physiol 2011; 156: 1725-1739.
94. Downing WL, Galpin JD, Clemens S, et al. Synthesis of enzymatically active human-l-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds. Plant Biotechnol J 2006; 4: 169-181.
95. Stöger E, Parker M, Christou P, Casey R. Pea legumin overexpressed in wheat endosperm assembles into an ordered paracrystalline matrix. Plant Physiol 2001; 125: 1732-1742.
96. Brinch-Pedersen H, Olesen A, Rasmussen SK, Holm PB. Generation of transgenic wheat (Triticum aestivum L.) for constitutive accumulation of an Aspergillus phytase. Mol Breeding 2000; 6: 195-206.
97. Nykiforuk CL, Shen Y, Murray EW, et al. Expression and recovery of biologically active recombinant Apolipoprotein AI(Milano) from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol J 2011; 9: 250-263.
98. Boothe JG, Saponja JA, Parmenter DL. Molecular farming in plants: Oilseeds as vehicles for the production of pharmaceutical proteins. Drug Develop Res 1997; 42: 172-181.
99. Boothe JG, Nykiforuk CL, Kuhlman PA, et al. Analytical characterization, safety and clinical bioequivalence of recombinant human insulin from transgenic plants. American Diabetes Association, 69th Scientific Sessions 2009: Abstract 5-LB.
100. Prescott VE, Campbell PM, Moore A, et al. Transgenic expression of bean alphaamylase inhibitor in peas results in altered structure and immunogenicity. J Agr Food Chem 2005; 53: 9023-9030.
101. Erlendsson LS, Muench MO, Hellman U, et al. Barley as a green factory for the production of functional Flt3 ligand. Biotechnology J 2010; 5: 163-171.
102. Stefanova G, Vlahova M, Atanassov A. Production of recombinant human lactoferrin from transgenic plants. Biol Plantarum 2008; 52: 423-428.
103. TAIR (The Arabidopsis Information Resource) [accessed online 1 September 2012]; Available at http://www.arabidopsis.org/
104. Boyes DC, Zayed AM, Ascenzi R, McCaskill AJ, Hoffman NE, Davis KR, Gorlach J. Growth stage-based phenotypic analysis of Arabidopsis: a model for high throughput functional genomics in plants. Plant Cell 2001; 13: 1499-1510.
105. Ruebelt MC, Lipp M, Reynolds TL, Astwood JD, Engel KH, Jany KD. Application of two dimensional gel electrophoresis to interrogate alterations in the proteome of genetically modified crops. 2. Assessing natural variability. J Agric Food Chem 2006; 54: 2162-2168.
106. Demeyer R, De Loose M, Van Bockstaele E, Van Droogenbroeck B. Exploiting the natural variation of Arabidopsis thaliana for the seed-specific production of proteins. Euphytica 2012; 183: 83-93.
107. Ramessar K, Capell T, Christou P. Molecular pharming in cereal crops. Phytochem Rev 2008; 7: 579-5592.
108. Ramessar K, Sabalza M, Capell T, Christou P. An ideal production platform for effective and safe molecular pharming. Plant Science 2008; 174: 409-419.
109. Watson SA. in: S.A. Watson, P.T. Ramstad (Eds.) Corn: Chemistry and Technology. Am. Assoc. Cereal Chemists, St. Paul, MN; 1987: 53-82.
110. Giddings G, Allison G, Brooks D, Carter A. Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol 2000; 18: 1151-1155.
111. Witcher DR, Hood EE, Peterson D, et al. Commercial production of b-glucuronidase (GUS): a model system for the production of proteins in plants. Mol Breed 1998; 4: 301-412.
112. Commandeur U, Twyman RM, Fischer R. The biosafety of molecular farming in plants. AgBiotechNet 2003; 5: ABN110.
113. Yamagata H, Tanaka K. The site of synthesis and accumulation of rice storage proteins. Plant Cell Physiol 1986; 27: 135-145.
114. Müntz K. Deposition of storage proteins. Plant Mol Biol 1998; 38: 77-99.
115. Yang D, Wu L, Hwang YS, Chen L, Huang N. Expression of the REB transcriptional activator in rice grains improves the yield of recombinant proteins whose genes are controlled by a Reb-responsive promoter. Proc Natl Acad Sci USA (PNAS) 2001; 98: 11438-11443.
116. Hennegan K, Yang D, Nguyen D, et al. Improvement of human lysozyme expression in transgenic rice grain by combining wheat (Triticum aestivum) puroindoline b and rice (Oryza sativa) Gt1 promoters and signal peptides. Transgenic Res 2005; 14: 583-592.
117. Lau OS, Sun SSM. Plant seeds as bioreactors for recombinant protein production. Biotechnol Adv 2009; 27: 015-022.
118. Faye L, Gomord V. Success stories in molecular farming a brief overview. Plant Biotechnol J 2010; 8: 525-528.
119. Philip R, Darnowski DW, Maughan PJ, Vodkin LO. Processing and localization of bovine bcasein expressed in transgenic soybean seeds under control of a soybean lectin expression cassette. Plant Science 2001; 161: 323-335.
120. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 2007; 25: 1647-1657.
121. Cunha NB, Murad A, Ramos GL, et al. Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res 2011; 20: 841-855.
122. Saalbach I, Giersberg M, Conrad U. High-level expression of a single-chain Fv fragment (scFv) antibody in transgenic pea seeds. J Plant Physiol 2001; 158: 529-533.
123. Mikschofsky H, Broer I. Feasibility of Pisum sativum as an expression system for pharmaceuticals. Transgenic Res 2011; DOI 10.1007/s11248-011-9573-z.
124. Boothe J, Nykiforuk C, Shen Y, et al. Seed-based expression systems for plant molecular farming. Plant Biotechnol J 2010; 8: 588-606.
125. Van Rooijen GJH, Moloney MM. Plant seed oil-bodies as carriers for foreign proteins. Nat Biotechnol 1995; 13: 72-77.
126. Paul M, Ma JKC. Plant-made pharmaceuticals: Leading products and production platforms. Biotechnol Appl Biochem 2011; 58: 58-67.
127. Spök A, Twyman RM, Fischer R, Ma JKC, Sparrow PAC. Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol 2008; 26: 506-517.
128. SemBioSys Genetics Inc. 2010; [Accessed online 1 September 2012] Available at http://micro.newswire.ca/36078-0.html?Start=15
129. Wilken LR, Nikolov ZL. Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 2012; 30: 419-433.
130. Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002; 8: 324-329.
131. Takagi H, Hiroi T, Yang L, et al. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA (PNAS) 2005; 102: 17525-17530.
132. Sexton A, Drake PM, Mahmood N, Harman SJ, Shattock, RJ, Ma JK. Transgenic plant production of Cyanovirin-N, an HIV microbicide. FASEB J 2009; 20: 356-358.
133. O'Keefe BR, Vojdani F, Buffa V, et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci USA (PNAS) 2009; 106: 6099-6104.
134. Naqvi S, Ramessar K, Farré G, et al. High-value products from transgenic maize. Biotechnol Adv 2011; 29: 40-53.
135. Ramessar K, Sabalza M, Miralpeix B, Capell T, Christou P. Can microbicides turn the tide against HIV? Curr Pharm Design 2010; 4: 468-485.
136. Shattock RJ, Rosenberg Z. Microbicides: Topical Prevention against HIV. Cold Spring Harbor Perspectives Medicine 2012; doi: 10.1101/cshperspect.a007385.
137. Naqvi S, Farre G, Sanahuja G, Capell T, Zhu C, Christou P. When more is better: multigene engineering in plants. Trends Plant Sci 2009; 15: 48-56.
138. Naqvi S, Zhu C, Farre G, et al. Transgenic multivitamin corn through biofortification of endosperm with three vitamins representing three distinct metabolic pathways. Proc Natl Acad Sci USA (PNAS) 2009; 108: 1-6.
139. Zhu C, Naqvi S, Breitenbach J, Sandman G, Christou P, Capell T. Combinatorial Genetic Transformation of Cereals and the Creation of Metabolic Libraries for the Carotenoid Pathway. Proc Natl Acad Sci USA (PNAS) 2008; 105: 18232-18237.
140. Chen Q. Expression and purification of pharmaceutical proteins in plants. Biol Engineering 2008; 2: 291-321.
141. Schillberg S, Zimmermann S, Findlay K, Fischer R. Plasma membrane display of anti-viral single chain Fv fragments confers resistance to tobacco mosaic virus. Mol Breed 2000; 6: 317-326.
142. Aspelund MT, Glatz CE. Purification of recombinant plant-made proteins from corn extracts by ultrafiltration. J Membr Sci 2010; 353: 103-110.
143. Farre G, Twyman RM, Zhu C, Capell T, Christou P. Nutritionally enhanced crops and food security: scientific achievements versus political expediency. Curr Opi Biotechnol 2011; 22: 245-251.
144. Ramessar K, Capell T, Twyman RM, Quemada H, Christou P. Trace and traceability a call for regulatory harmony. Nat Biotehnol 2008; 26: 975-978.
145. Ramessar K, Capell T, Twyman RM, Christou P. Going to ridiculous lengths-European coexistence regulations for GM crops. Nat Biotechnol 2010; 28: 133-136.
146. Sabalza M, Miralpeix B, Twyman RM, Capell T, Christou P. EU legitimizes GM crop exclusion zones. Nat Biotechnol 2011; 29: 315-317.
147. Twyman RM, Ramessar K, Quemada H, Capell T, Christou P. Plant biotechnology: the importance of being accurate. Trends Biotechnol 2009; 27: 609-612.
148. Ramessar K, Capell T, Twyman RM, Quemada H, Christou P. Calling the tunes on transgenic crops: the case for regulatory harmony. Mol Breed 2009; 23: 99-112.